PitchSend

Investor Presentaiton

RECENT DEVELOPMENTS Q Acquired YUTIQ - Immediately accretive acquisition leveraging existing Alimera infrastructure Q Expanded U.S. Commercial Team - Increased field personnel by more than 20% for expanded reach and frequency with retinal physicians Q Refinanced Debt - Amended its $45 million term loan agreement, extending interest- only period for at least two years and extend the final maturity date to April 30, 2028 Nasdaq: ALIM E alimera FP 14

View entire presentation